Physician Independence and California Corporate-Practice-of-Medicine Issues

Scope and warning#

This Roadmap explains California's corporate-practice rules as they bear on physicians' professional independence: the core prohibition, statutory exceptions, the medical corporation, the Medical Board's stated position on decisions reserved to physicians, management services organizations, fee-splitting and referral rules, and the 2025 private-equity and hedge-fund statute.

It does not decide whether any arrangement is lawful. It does not address dental-practice rules except where the 2025 statute treats physician and dental practices together. It does not cover hospital medical-staff governance, credentialing, or peer review (Roadmap 032), or the day-to-day conflict between clinical judgment and administrative direction (Roadmap 031). Nor does a public-agency detention contract, without more, establish that its private medical-services vendor qualifies for a §2401 employing exception or the §1190 private-equity/public-agency exclusion.

Corporate-practice questions are highly document-specific. A clause that looks innocuous in isolation can matter in combination with others, and a clause that looks troubling may be balanced by a provision reserving final authority to a physician. Nothing here substitutes for review of the actual agreements and decision records by counsel.

The factual situation this roadmap addresses#

Consider a hypothetical physician employed by a California medical corporation that provides clinical services under contracts with public agencies. The medical corporation has a services agreement with a separate management company. Over time, the management company's regional office begins issuing patient-volume targets, revises a clinical protocol, selects medical supplies, issues coding instructions, and recommends against renewing the physician's contract after the physician objects in writing to the revised protocol. A physician officer of the medical corporation signs the non-renewal letter, but the internal recommendation and approval trail has not yet been obtained. The officer's signature is evidence of formal action, not conclusive evidence of independent physician review.

The physician asks whether the management company was practicing medicine, whether the protocol change or the non-renewal was unlawful, and whether anything follows from that.

The analysis separates four questions: what the governing documents say about who decides each category of decision; who actually made each decision; whether any statute was violated; and which legal theory, if any, would give the physician a remedy.

Governing law#

Each statement below carries a certainty grade. A grade describes the whole statement it follows.

The core rule

Business and Professions Code §2400 provides that corporations and other artificial legal entities "shall have no professional rights, privileges, or powers." The same section allows the licensing authority, by regulation, to approve salaried employment of licensees by licensed charitable institutions, foundations, or clinics that make no charge for professional services. Settled (statutory text).

The California Court of Appeal has described the question whether a contract between a physician and a non-licensee results in the non-licensee's unlicensed practice of medicine as one that "turns on whether the non-licensee exercises or has retained the right to exercise control or discretion over the physician's practice," determined by interpreting the agreement's substantive provisions (Epic Medical Management, LLC v. Paquette (2016) 244 Cal.App.4th 504, citing a 1972 Attorney General opinion and People v. Superior Court (Cardillo) (2013)). Prevailing (published Court of Appeal decision).

Statutory exceptions — with an anti-interference proviso

Section 2401 provides different, conditional exceptions to §2400; they are not a blanket exception for correctional facilities, county service contractors, or any organization calling itself a clinic. Subdivision (a) concerns a qualifying nonprofit university medical-school teaching clinic charging for services provided by faculty licensees under specified approvals; it does not itself grant a general physician-employment exemption. Subdivisions (b) and (c) address qualifying Health and Safety Code §1206(a) clinics and regulated narcotic-treatment programs. Subdivisions (d) and (e) concern narrowly described pediatric charitable and federally certified critical-access hospitals and impose additional conditions. The prohibition on interfering with physician professional judgment expressly appears in subdivisions (b)–(e), with the pediatric and critical-access provisions phrased as specific conditions. Section 2400 and other law remain relevant to every arrangement. Statutory reproduction checked; verify current official code before legal reliance.

The structure matters. Even where the Legislature permits an entity to employ physicians, it preserves the physician's professional judgment as a separate protected sphere.

The medical corporation

Physicians commonly practice through a medical corporation. Section 2408 provides that, except as allowed by Corporations Code §§13401.5 and 13403, each shareholder, director, and officer of a medical corporation — other than an assistant secretary or assistant treasurer — must be a licensed person, and it allows a single-shareholder medical corporation to be a shareholder of another medical corporation. The same section expressly permits a non-licensed person to use administrative business titles such as chief executive officer or executive vice president within the professional corporation. Settled (statutory text).

Medical-corporation ownership and governance cannot be reduced to "physician-owned" versus "corporate-owned." Sections 2408 and Corporations Code §§13401.5 and 13403 establish nuanced licensed-person and professional-corporation arrangements and exceptions. A nonlicensed person may hold an administrative title, but that title does not create clinical authority. Verify actual share classes and voting rights, shareholder licensure, physician-board appointment/removal powers, proxies, loans or options, reserved vetoes, and who had effective approval authority at the date of each disputed decision. The mere identity of the payroll or HR provider does not prove either lawful compliance or unlawful domination. Statutory text and Medical Board guidance; entity application unproved.

The Medical Board's stated position on reserved decisions

The Medical Board of California's official guidance distinguishes physician-only clinical decisions from specified practice-management decisions that effectively control medical judgment. It identifies nonlicensed ownership of businesses delivering diagnosis or treatment, an MSO arranging for or providing clinical services, and a nominal "medical director" for a nonphysician-owned medical practice as potentially prohibited structures. Its medical-director example concerns a business performing medical procedures, not every employed medical director or county-appointed physician. The Board's position supplies regulatory context but does not prove a violation without the particular ownership, licensure, service, and authority evidence. Official agency guidance reviewed; facts unestablished.

For private-equity groups and hedge funds, the Legislature has now codified a closely parallel list in statute (next subsection). For everyone else, the Board's list remains guidance that a regulator applies and a court may consider, read together with §2400 and the control test.

Management services organizations

California law permits nonclinical management services without conceding clinical authority. In Epic Medical Management, LLC v. Paquette (2016) 244 Cal.App.4th 504, the court reviewed an arbitration award under a management arrangement supplying facilities, billing, equipment, support personnel, and marketing. Its CPOM conclusion rested on the contract's substantive delineation between physician-controlled medicine and management-controlled nonclinical services; its §650 analysis depended on record-specific comparisons between fees, costs, and services, not a general validation of revenue-sharing. The court affirmed a narrow arbitration judgment, not the legal sufficiency of every MSO or "friendly physician" arrangement. A party alleging different facts must identify the different contract powers, actual conduct, and compensation/referral evidence. Published appellate opinion; distinguish facts and procedural posture.

The arbitration analysis in Epic concerns post-award judicial review, not whether a party can plead a statutory claim, request pre-award relief, or contest an agreement's enforceability in an appropriate forum. The court distinguished illegality alleged to taint the entire contract from partial illegality ordinarily for the arbitrator, and recognized narrow public-policy exceptions to arbitral finality. Evaluate the agreement, arbitration posture, remedy sought, and any later governing authority separately; do not cite Epic as blanket immunity for illegal management decisions. Published opinion; subsequent history and applicability remain open.

Reading a management agreement: a method

Because the control test turns on substantive terms and operative practice, examine the executed agreement, its effective-date amendments, schedules, side letters, employment/board instruments, and a contemporaneous decision trail. A manager's contractual power to override a clinical decision matters even if rarely exercised; formal physician signatures alone do not answer whether approval was independent. The following sequence is an evidence-collection protocol, not a finding of illegality.

1. Scope clause. Identify how the agreement describes the services — for example, as services for the "non-medical aspects" of the practice — and whether any listed service reaches clinical subjects.
2. Reserved-powers clause. Look for a provision reserving clinical judgment and the business decisions listed in §1191(a)(2) and the Medical Board's guidance to licensed physicians, and note whether it gives physicians final approval or only consultation rights.
3. Personnel clauses. Determine who selects, supervises, evaluates, disciplines, and terminates clinicians and clinical staff, and whether any of those decisions is based on clinical competency.
4. Policies and protocols. Determine who drafts, approves, and may override clinical protocols, formularies, and utilization rules.
5. Productivity and scheduling. Determine who sets patient-volume expectations and physician hours, and whether those are framed as clinical requirements or as administrative scheduling.
6. Records, coding, and billing. Determine who owns medical records and who decides coding and billing for patient-care services.
7. Compensation. Determine how the manager is paid, and whether a percentage-based fee is tied to services and property actually provided (§650(b)).
8. Restrictive covenants. Identify non-compete, non-disparagement, and confidentiality clauses, and whether Division 1.7 may reach them.
9. Appointment and veto rights. Review who can appoint or remove physician directors, change bylaws or protocols, veto budgets that determine clinical staffing, terminate the MSO arrangement, or trigger a stock-transfer option; identify legal versus practical control without assuming every investor protection is clinical control.
10. Course of dealing. Compare written allocation with dated recommendations, approvals, reversals, and operational decisions; Epic also illustrates that a tribunal may find modification through conduct despite written-amendment language.
11. Period and source. Record which party held each power before January 1, 2026, and after; preserve exact language and source provenance. For any conduct alleged under §1191, independently establish covered actor and practice status.

Each answer should be tied to a clause and a dated record. The method describes facts; it does not decide legality. Settled method.

Fee-splitting and referral consideration

Business and Professions Code §650(a) generally prohibits specified consideration as compensation or inducement for patient referrals. Section 650(b) permits percentage-of-gross-revenue or comparable consideration for services other than referrals when commensurate with the services actually furnished or the fair rental value of the premises or equipment supplied. The 2016 Epic opinion applied those provisions to an evidentiary record with management services and a cost comparison; it did not bless payments for referrals. Review the fee base, affiliated referrers, allocation of services, invoices, fair-value evidence, payer mix, and whether continuing payments compensate pretermination services or posttermination referrals. Other potentially applicable state or federal referral laws require separate review. Statutory reproduction and published appellate opinion; no agreement-specific conclusion.

A percentage management fee is neither automatically unlawful nor automatically permissible. A defensive fair-value opinion must be tested against contemporaneous cost and service records; a claimant's bare percentage comparison is likewise insufficient. Do not infer a §650 violation from an MSO label, a billing role, overlapping referral relationships, or a percentage clause without testing consideration and causation. Adversarial legal application; factual verification required.

Private-equity groups and hedge funds: Health and Safety Code §§1190–1192

Senate Bill 351 (Stats. 2025, ch. 409), approved and filed October 6, 2025, added Division 1.7 to the Health and Safety Code. Its operative provisions are:

• Definitions (§1190). Section 1190 defines the covered hedge fund and private equity group separately, with exclusions that must be applied to the correct category. Passive contributors without specified management/control participation, qualifying hospitals or hospital systems and affiliates or controlled entities, and public agencies (including described publicly connected facilities) are excluded under the relevant definitions. The express secured-debt-financing exclusion appears in the hedge-fund definition; it is not a categorical safe harbor for every financing or control structure. A named fund, lender, bankruptcy creditor, administrator, or corporate parent is not necessarily a covered actor. Examine the ownership, management, and control chain at the relevant date.
• Clinical judgment (§1191(a)(1)). A private-equity group or hedge fund "involved in any manner" with a physician or dental practice doing business in California — including as an investor in the practice or as an investor or owner of its assets — may not interfere with physicians' or dentists' professional judgment in health-care decisions, including determining appropriate diagnostic tests; determining the need for referrals or consultations; responsibility for the ultimate overall care of the patient, including treatment options; and determining how many patients a physician or dentist sees in a period or how many hours they work.
• Business control (§1191(a)(2)). It may not exercise control over, or be delegated the power to do, any of the following: owning or determining the content of patient medical records; selecting, hiring, or firing clinicians and staff based in whole or part on clinical competency or proficiency; setting parameters for contracting with third-party payers; setting clinical-competency parameters for contracting with other physicians or dentists; making coding and billing decisions for patient care services; or approving the selection of medical equipment and supplies.
• Form irrelevant (§1191(b)). The practice's corporate form does not affect application.
• Contracts (§1191(c)). For subdivision (c), covered groups or funds and entities controlled directly, in whole or in part, by them must not enter agreements enabling the prohibited interference or reserved control; contractual provisions violating subdivision (a) are void. This text does not automatically void a whole management agreement or make an unrelated subsidiary a defendant. Identify the operative provision, contracting parties, control basis, and relevant time; evaluate severability and other enforcement questions separately.
• Non-compete and non-disparagement (§1191(d)). Subdivision (d) addresses contracts involving practice management or sale of practice-owned real estate or other assets to a covered fund/group or an entity controlled directly or indirectly, in whole or in part by one. It voids covered restrictions on providers' post-departure competition or commentary concerning listed quality, utilization, ethical, professional, or investor revenue issues. Subdivision (d)(3) preserves an otherwise enforceable genuine sale-of-business noncompete but not an employee noncompete disguised in the transaction. It also preserves otherwise valid confidentiality protecting investor/fund material nonpublic information only within the statute's express carve-outs for legally required disclosures and protected commentary. The specific agreement, capacity, transaction, restriction, and effective period remain dispositive.
• Enforcement (§1191(e)). The Attorney General is entitled to injunctive and other equitable relief and to recover fees and costs.
• Purpose and limits (§1191(f)–(h)). The section is intended to keep clinical decisionmaking exclusively with licensed providers; it does not narrow or lower the existing corporate-practice bar; and it does not prohibit unlicensed persons from assisting or consulting on the listed business decisions so long as the physician or dentist retains ultimate responsibility for, or approval of, them.
• Severability (§1192). Settled (statutory text); application to any entity Fact-dependent.

Operative timing: SB 351 was approved and chaptered October 6, 2025; absent a special operative-date provision, California's normal regular-session rule made it effective January 1, 2026 (California Constitution, article IV, §8(c); California Secretary of State guidance). A contract signed in 2025 may still create prospective 2026 compliance questions if performance, control, or enforcement continued into 2026; that does not establish retroactive penalties or liability for completed pre-2026 conduct. The chaptered bill text itself does not expressly resolve every retroactivity and accrued-right question. Segregate conduct by date and have counsel assess transitional issues without claiming a statutory grandfather clause or a conclusive retroactivity rule.

Public agencies stand apart under the 2025 statute

Section 1190 excludes public agencies and described facilities or settings owned, operated, managed, controlled, or affiliated with such agencies from its definitions. A California county is not reclassified as a private-equity group merely by purchasing health services. A private contractor does not inherit a blanket public-agency exception just because it serves a county. The correct unit of analysis is the actual fund/group, intermediate entity, practice, and contract at the relevant date; ask separately whether the practice is doing business in California and whether the investor or manager is covered. These exclusions do not independently establish a §2401 exception to the underlying CPOM doctrine. Statutory reproduced text; status requires corporate and public-contract documents.

What a corporate-practice concern can and cannot do in an employment dispute#

A corporate-practice concern can matter in at least five ways, none of which is automatic.

It can identify the real decisionmaker. If a non-physician manager or affiliated company in fact decided a clinical-competency termination, a protocol, or patient-volume targets, that fact bears on who made the employment decision and why. Roadmap 005 supplies the method. Analytical inference — evidentiary use.

It can be the subject of protected reporting. A qualifying disclosure of information that an employee reasonably believes reveals a legal violation may be protected under Labor Code §1102.5, including appropriately supported suspected CPOM violations, if statutory recipient/activity and causation elements are met. Merely disputing an operational preference or using the phrase "corporate practice" does not by itself establish protected disclosure. Record the exact communication, date, recipient and authority, perceived legal violation, decisionmaker knowledge, and evidence of contrary legitimate grounds. Medical-appropriateness advocacy has separate requirements under Business and Professions Code §§510 and 2056 (Roadmap 022), which should not be folded into §1102.5. Separate statutes; factual application unresolved.

It can affect contract enforceability. Contract provisions that violate §1191(a) are void, and covered non-compete and non-disparagement clauses in covered management or asset-sale contracts are void (§1191(c)(2), (d)(2)). More generally, illegality may be raised as a defense to enforcement of a contract, subject to the limits Epic Medical Management describes, particularly where the dispute is in arbitration. Roadmaps 028 and 029 address contract and arbitration enforceability. Settled as to Division 1.7 text; general illegality doctrine Fact-dependent.

It can support regulatory action. The Attorney General may enforce §1191, and the Medical Board applies the Medical Practice Act. Those are regulatory processes, not private lawsuits.

It does not, by itself, create a damages claim. Section 2400 does not state a private damages remedy, and §1191's text provides Attorney General enforcement and contract voidness rather than a private damages action. Whether a corporate-practice violation can support a public-policy wrongful-discharge claim or another private theory depends on that theory's own requirements and has not been resolved on this page. Analytical reading of text; private remedies Unsettled.

Elements of the claim#

A corporate-practice concern is not itself a claim. The related claims each have their own elements:

• Whistleblower retaliation (Labor Code §1102.5). Protected disclosure of reasonably believed legal violations; adverse action; contributing-factor causation; the employer's clear-and-convincing same-decision defense (Roadmap 021).
• Physician advocacy (Business and Professions Code §§510, 2056). Qualifying advocacy for medically appropriate care and adverse action principally for that advocacy, subject to the statutes' limits for legitimate peer and utilization review (Roadmap 022).
• Public-policy wrongful discharge. An employment relationship, termination, a fundamental and well-established public policy tethered to a statute or constitutional provision, a substantial motivating connection, and harm (Roadmap 011). Whether §2400 or Division 1.7 supplies the necessary policy for a particular discharge is not settled on this page.
• Contract claims and defenses. Formation, breach, damages; or, defensively, voidness or illegality of a term (Roadmap 028).

Potentially relevant defendants#

The defendant depends on the claim. For an employment claim, the defendant is ordinarily the legal employer, identified from employment documents (Roadmaps 003–005). For Division 1.7 enforcement, the regulated parties are private-equity groups, hedge funds, and entities they control, and enforcement belongs to the Attorney General.

Payroll processing, HR administration, branding, and a parent affiliation do not by themselves identify the employing or responsible legal entity. Analyze employer status and liability under the specific employment-law test, independent of §1191's investor/controlled-entity restrictions; do not treat corporate affiliation as automatic joint employment, agency, alter ego, or successor responsibility. Subdivision (c) refers to direct control; subdivision (d) expressly reaches direct or indirect control. The different words matter, and each statutory subsection requires actor- and contract-specific proof. No person-specific or entity-specific determination made.

Administrative prerequisites#

Corporate-practice concerns can be reported to the Medical Board and the Attorney General; those reports are not prerequisites to any private claim. Each related private claim carries its own prerequisites — for example, none for a Labor Code §1102.5 civil action under Labor Code §244, and administrative exhaustion for FEHA claims (Roadmaps 021, 023, 034, 035).

Limitation periods#

Neither §2400 nor Division 1.7 states a limitations period for private litigants, because neither creates a private damages action on its face. The relevant periods are those of the related claim: Labor Code §1102.5 claims (Roadmap 021), public-policy discharge (Roadmap 011), contract claims (Roadmap 028), and administrative routes (Roadmaps 034, 035). This page states no period of its own.

Evidence and records to obtain#

Corporate-practice analysis requires an actor–power–decision–date–document matrix rather than conclusions from the org chart. For each disputed event, record formal approval, actual initiating actor, approval/rejection ability, physician review (substantive or nominal), a contrary explanation, and whether conduct predated January 1, 2026. Preserve chain of custody, provenance, and redactions. Useful records include:

• the fully executed management or services agreement, every dated amendment, delegated-authority schedule, side letter, option, and termination right;
• capitalization and voting instruments, shareholder registers obtainable by lawful means, board designation/removal rights, asset pledges, investor consent and reserved veto rights (including negative control);
• the medical corporation's articles, bylaws, and public Statements of Information identifying directors and officers, and — where lawfully obtainable — records of shareholders;
• documents appointing medical directors and defining their authority;
• clinical protocols, formularies, and utilization or staffing policies, with author, approver, and effective date;
• productivity, scheduling, and patient-volume directives and who issued them;
• coding and billing instructions and who issued them;
• supply and equipment approvals;
• hiring, credentialing-related employment decisions, discipline, and non-renewal records showing who recommended and who decided;
• non-compete, non-disparagement, and confidentiality provisions in employment, management, or asset agreements;
• public contracts and board minutes where a public agency purchases services.

Records to obtain lawfully

Use the statutory personnel-file and payroll-record procedures, public-records requests to public agencies, corporate filings, and discovery. Do not remove confidential business documents, patient records, or peer-review materials outside lawful channels.

Favorable and adverse facts#

Facts that suggest non-physician control

Written directives from non-licensed personnel setting clinical protocols, diagnostic or referral rules, patient-volume targets, or physician hours; coding instructions issued without physician approval; staff selection or termination by non-licensed personnel based on clinical competency; agreements delegating those powers; physicians' approvals that were nominal or after the fact; and non-compete or non-disparagement clauses in covered management contracts.

Facts that suggest lawful separation

Agreements that reserve final clinical and listed business decisions to appropriately licensed physicians; contemporaneous minutes and change histories documenting real physician approval; physician power to override disputed nonclinical recommendations; administrative support confined to lawful functions; fees commensurate with documented value; and consultation on §1191(a)(2) business decisions with ultimate physician approval under §1191(h). None establishes compliance alone if contrary operational evidence exists.

Strongest contrary evidence and how to test it

A defense may produce signed physician approvals, preexisting utilization requirements, a security policy, or quality concerns explaining a decision without nonlicensed clinical control. Test those records against their creation dates, final-authority clauses, meeting attendance, clinical-review notes, changes following objections, and comparable decisions. Conversely, a claimant's inference from ownership, a contract title, investor communications, or apparent pressure must be tested against evidence that independent physicians actually decided and could veto the disputed matters. Neither side's characterization substitutes for authenticated records.

Likely defenses#

Expect arguments that the arrangement allocates only non-medical functions; that a licensed physician retained ultimate responsibility or approval (§1191(h)); that administrative titles are permitted (§2408); that an employing entity falls within a §2401 exception; that the party is not a private-equity group or hedge fund, or is excluded as a public agency or hospital system (§1190); that any alleged illegality goes only to part of a contract (Epic Medical Management); that no private right of action exists; that the employment decision rested on legitimate, independent reasons; and that the dispute must be arbitrated.

Causation#

A corporate-practice concern and an adverse employment action are linked only through a recognized claim. Under Labor Code §1102.5, the question is whether protected disclosure was a contributing factor; under the physician-advocacy statutes, whether the action was taken principally for qualifying advocacy; under a public-policy theory, whether the policy-protected conduct was a substantial motivating reason. In every case the analysis maps who knew of the protected conduct, who recommended the action, and who decided it.

Damages and remedies#

Section 1191(e) expressly entitles the Attorney General, not a private claimant, to injunctive and other court-appropriate equitable relief plus enforcement fees and costs. Sections 1191(c)(2) and (d)(2) specify voidness of violating provisions; whether other provisions survive requires contract-specific analysis. The Medical Board has separate regulatory authority under the Medical Practice Act. Nothing on the face of §§2400 or 1191 grants a general private compensatory remedy for a CPOM violation, but an independently pleaded employment, contract, or statutory claim may supply relief if its own elements and defenses are proved. This Roadmap makes no determination of private standing or remedial entitlement.

Discovery#

Discovery should test who possessed contractual control and who exercised it for each decision category: executed corporate instruments and amendments; medical-director appointment/removal and board delegation; ownership and investor status at relevant dates; authentic approval trails for protocols, clinical staff, coding, and supplies; manager–physician communications; compensation and referral-service valuation; and decisionmaker knowledge of any protected reports. Tailor requests to issues, time, proportionality, privilege, privacy, and any applicable protective-order process; financial and ownership records are not automatically shielded by a protective order. Avoid treating privileged legal advice, peer-review records, or patient data as freely discoverable.

CFMG/Wellpath-specific relevance#

The separate public CFMG–Wellpath investigation has described a medical-professional-corporation/management relationship. That source's characterization is inherited reporting, not an independently authenticated finding in this Roadmap. This manuscript makes no independent assertion of the ownership chain, investor classification, exact employment relationships, or physician-reserved powers in any relevant year. Compare entity names against original filings, contracts, and dated governance instruments before connecting any public reporting to statutory elements.

The controlling question is the one the investigation uses: when an administrative issue became a physician-reserved decision, who had the last word? Each decision category in §1191(a) and in the Medical Board's guidance can be traced through the documents to a person and an entity.

Entity precision applies throughout. California Forensic Medical Group, Inc.; Wellpath CFMG, Inc.; Wellpath LLC and other Wellpath entities; holding companies; investors; and counties are distinct. Statements about shareholders, ownership, or private-equity control require primary instruments for the relevant period, not inference from branding or press coverage. A county's role as purchaser of services does not make it a private-equity group, and the 2025 statute expressly excludes public agencies.

This Roadmap makes no finding that any CFMG or Wellpath entity practiced medicine unlawfully, that any agreement is void, that any entity is controlled by a private-equity group, or that any person has a claim.

Primary authorities#

Related roadmaps#

• Roadmap 004 — corporate structure; Roadmap 005 — decisionmaker method.
• Roadmap 010 — termination framework; Roadmap 011 — public-policy discharge.
• Roadmaps 020–023 — retaliation, whistleblowing, physician advocacy, reporting to regulators.
• Roadmap 028 — contracts; Roadmap 029 — arbitration.
• Roadmap 031 — professional judgment versus administrative direction.
• Roadmap 032 — credentialing, privileges and peer review.

Companion worksheet#

A decision-authority worksheet should list each category—diagnostic testing, referrals, treatment, volume and hours, records, clinical-competency staffing, payer and professional contracting, coding and billing, equipment and supplies—and preserve: relevant document version and clause; actor's licensure and employing/appointing entity; formal approver versus initiator; consent/veto and appointment/removal rights; date (before or after Jan. 1, 2026); contemporaneous evidence and hash; and strongest competing lawful explanation. Keep §1191(a)(1) clinical interference distinct from §1191(a)(2) listed business powers because §1191(h)'s consulting qualification expressly refers only to the latter.

A second block should record each non-compete, non-disparagement, or confidentiality clause, the contract it appears in, the parties, and whether any party may be a private-equity group, hedge fund, or controlled entity — as a question for counsel, not a conclusion.

What this page cannot do#

This Roadmap cannot determine whether a specific actor exercised prohibited clinical or management control, whether an agreement provision is void, whether a named investor is a defined fund/group or controlled entity, whether Division 1.7 applies to each relevant period, or whether any person can invoke an independent cause of action. Human legal review must separately decide current statutory text, temporal application, standing, remedies, and later treatment of controlling cases.

Those questions require governing documents, ownership and voting records for each period, authentic clinical-decision records, current law, and counsel review. Source status for this private correction candidate: the Medical Board's CPOM guidance and Secretary of State's statute-effective-date explanation were accessed on their official sites; the SB 351 chaptered text, §§2400–2401, 2408, 650, and Corporations Code §13403 were checked through identified reproductions; the official Legislature SB 351 endpoint returned HTTP 403. The published Epic opinion was read in a court-decision reproduction, not through a subsequent-history citator. These are source-specific research observations, not a certification of all current law or publication readiness.